Details werden geladen...
AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5 billion | Fortune
“We want to be the SpaceX of the pharmaceutical industry,” Alex Zhavoronkov, co-CEO of Insilico Medicine tells Fortune.
Ähnliche Seiten
Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders | The Manila Times
https://www.manilatimes.net/2026/06/22/tmt-newswire/pr-newswire/insilico-medicine-and-sk-biopharmaceuticals-achieved-ai-powered-drug-discovery-collaboration-worth-up-to-25-billion-for-neuroimmune-disorders/2369761
China's Innovent Biologics signs drug deal with Pfizer worth up to $10.5bn - Nikkei Asia
https://asia.nikkei.com/business/pharmaceuticals/china-s-innovent-biologics-signs-drug-deal-with-pfizer-worth-up-to-10.5bn
SpaceX signs $30 billion AI deal with Google — RT World News
https://www.rt.com/news/641106-spacex-ai-deals-google-anthropic/
Cursor’s 25-year-old CEO is a former Google intern who just cemented a $60 billion deal with SpaceX | Fortune
https://fortune.com/article/who-is-michael-truell-cursor-ceo-spacex-acquisition/CEO of $20 billion AI firm Perplexity says the secret to success is ‘sleeping with that fear’ that your competitor will steal your idea | Fortune
https://fortune.com/article/perplexity-cofounder-ceo-aravind-srinivas-secret-success-embracing-fear-competitor-steal-idea-ai-gen-z/